We’re just about to the end of 2024, and it’s been an exciting year at VetStem. This year we were pleased to announce the commercial launch of our FDA-reviewed off-the-shelf PRP product, PrecisePRP. As we do every year, we’re wrapping up the VetStem blog with some highlights from the last 12 months. So, without further ado, here is VetStem’s 2024 year in review!

• In early 2024, we announced that VetStem reached a significant industry leading milestone. As of February, we had processed over 16,000 patient samples resulting in over 38,000 stem cell treatments.
• At the same time, two of our most prolific small animal users reached a milestone in stem cell cases. Drs. Jeff Christiansen and Kim Carlson both surpassed 300 cases. To date, Dr. Christiansen has performed 342 stem cell collections and Dr. Carlson has performed 326 – wow!
• In mid April, VetStem sponsored a lab at the annual IVAPM Pain Management Forum for the third year in a row. Veterinarians at this forum have a particular interest in multi-modal pain management and were excited to learn about PrecisePRP.
• Later in April, we were thrilled to announce that our latest platelet-rich plasma product, PrecisePRP Canine, had completed FDA review and officially became the first FDA-reviewed allogeneic off-the-shelf cell medicine product in the U.S.
• Shortly afterward, we announced the launch of PrecisePRP Equine, the second allogeneic cell medicine product to complete FDA-review.
• In May, the VetStem Sales and Marketing team was in Nashville where we sponsored and exhibited at the Fetch DVM360 Nashville veterinary conference. VetStem proponent and pain specialist Dr. Jamie Gaynor delivered two lectures about stem cell therapy and platelet-rich plasma.
• In July, we shared a fun update about a Sichuan Takin that received VetStem Cell Therapy for arthritis.
• August saw the VetStem Sales and Marketing team in Kansas City, MO for the annual Fetch DVM360 conference. We sponsored and exhibited at this show where our CEO, Dr. Bob  Harman, delivered two lectures about regenerative medicine.
• In October, we released updated efficacy data for PrecisePRP Canine. Out of 59 dogs who received PrecisePRP for orthopedic conditions, 47 of them showed significant improvement!
• Also in October, the Sales and Marketing team was back on the road at the Fetch Coastal veterinary conference in Atlantic City, NJ. VetStem proponent Dr. Alistair Chapnick delivered two lectures on stem cell therapy and PRP.
• In early December, the Sales and Marketing team wrapped up a busy year of conferences at the final Fetch DVM360 conference in Long Beach, CA. At this show, Drs. Bob Harman and Jamie Gaynor teamed up to deliver two lectures about comprehensive management of osteoarthritis and regenerative medicine.

So, there you have it. Another year in the books. It was an exciting year for us and, as always, we couldn’t do what we do without the support of our veterinary and pet owner clients. We hope that you and your loved ones have a wonderful holiday season, and we look forward to seeing what 2024 has in store for VetStem!